BeyondSpring, Inc. - stock earnings
BYSI Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 6, 2024 BeforeMarket | - / - | - | - / 30.0 million | - |
BYSI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -6.4 million USD | 437500 USD |
| 2023Q1 | -7.4 million USD | 337500 USD |
| 2022Q4 | -9.2 million USD | 338000 USD |
| 2022Q3 | -7.4 million USD | 337500 USD |
| 2022Q2 | -9.2 million USD | 338000 USD |
| 2022Q1 | -10.7 million USD | 338000 USD |
| 2021Q4 | -10.7 million USD | 338000 USD |
| 2021Q3 | -20.1 million USD | 337000 USD |
| 2021Q2 | -19.3 million USD | 338000 USD |
| 2021Q1 | -17.6 million USD | 180000 USD |
| 2020Q4 | -17.6 million USD | 180000 USD |
| 2020Q3 | -14.5 million USD | ? USD |
| 2020Q2 | -12.8 million USD | ? USD |
| 2020Q1 | -14.1 million USD | ? USD |
| 2019Q4 | -14.1 million USD | ? USD |
| 2019Q3 | -9.4 million USD | ? USD |
| 2019Q2 | -7.3 million USD | ? USD |
| 2019Q1 | -14.1 million USD | ? USD |
| 2018Q4 | -14.1 million USD | ? USD |
| 2018Q3 | -14.9 million USD | ? USD |
| 2018Q2 | -12.2 million USD | ? USD |
| 2018Q1 | -15.5 million USD | ? USD |
| 2017Q4 | -15.5 million USD | ? USD |
| 2017Q3 | -15.5 million USD | ? USD |
| 2017Q2 | -13.3 million USD | ? USD |
| 2017Q1 | -3.5 million USD | ? USD |
| 2016Q4 | -3.5 million USD | ? USD |
| 2016Q3 | -3.1 million USD | ? USD |
| 2016Q2 | -3.5 million USD | ? USD |
| 2016Q1 | -1.8 million USD | ? USD |
| 2015Q4 | -2.0 million USD | ? USD |
| 2014Q4 | -3.0 million USD | ? USD |
BYSI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -36.3 million USD | 1.4 million USD |
| 2021 | -68.2 million USD | 1.4 million USD |
| 2020 | -61.1 million USD | 180000 USD |
| 2019 | -38.3 million USD | ? USD |
| 2018 | -54.9 million USD | ? USD |
| 2017 | -91.8 million USD | ? USD |
| 2016 | -12.0 million USD | ? USD |
| 2015 | -8.0 million USD | ? USD |
| 2014 | -3.0 million USD | ? USD |
BYSI
Price: $2.25
52 week price:
Earnings Per Share: -0.71 USD
P/E Ratio: -1.90
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 157900
Ebitda: -18.6 millionMarket Capitalization: 74.5 million